• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿米替林可使丁苯那嗪引起的脑微循环变化恢复正常。

Amitriptyline normalizes tetrabenazine-induced changes in cerebral microcirculation.

作者信息

Kent T A, Preskorn S H, Glotzbach R K, Irwin G H

出版信息

Biol Psychiatry. 1986 May;21(5-6):483-91. doi: 10.1016/0006-3223(86)90190-3.

DOI:10.1016/0006-3223(86)90190-3
PMID:3697438
Abstract

The cerebromicrocirculation in the tetrabenzaine (TBZ) model of depression has been found to be abnormal with respect to (1) responsiveness of cerebral blood flow to increases in arterial CO2 content and (2) the effective permeability of the blood-brain barrier to water. Development of these abnormalities temporally paralleled the behavioral disturbances and catecholamine depletion induced by TBZ. These TBZ-induced changes occurred globally throughout the brain, being apparent in the forebrain, cerebellum, and medulla-pons. Pretreatment with the antidepressant amitriptyline prevented both behavioral and physiological effects of TBZ, whereas amitriptyline administered after TBZ was less effective. The results suggest that an important action of tricyclic antidepressants may be cerebromicrocirculatory effects.

摘要

在丁苯那嗪(TBZ)诱导的抑郁症模型中,已发现脑微循环存在异常,具体表现为:(1)脑血流量对动脉血二氧化碳含量增加的反应性;(2)血脑屏障对水的有效通透性。这些异常的发展在时间上与TBZ诱导的行为障碍和儿茶酚胺耗竭相平行。这些由TBZ诱导的变化在全脑普遍存在,在前脑、小脑和延髓-脑桥中都很明显。用抗抑郁药阿米替林预处理可预防TBZ的行为和生理效应,而在TBZ给药后给予阿米替林则效果较差。结果表明,三环类抗抑郁药的一个重要作用可能是对脑微循环的影响。

相似文献

1
Amitriptyline normalizes tetrabenazine-induced changes in cerebral microcirculation.阿米替林可使丁苯那嗪引起的脑微循环变化恢复正常。
Biol Psychiatry. 1986 May;21(5-6):483-91. doi: 10.1016/0006-3223(86)90190-3.
2
Cerebromicrocirculatory defects in animal model of depression.抑郁症动物模型中的脑微循环缺陷
Psychopharmacology (Berl). 1984;84(2):196-9. doi: 10.1007/BF00427445.
3
Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants.
Eur J Pharmacol. 1984 Jul 20;102(3-4):425-30. doi: 10.1016/0014-2999(84)90562-4.
4
Role of the central adrenergic system in mediating amitriptyline-induced alteration in the mammalian blood-brain barrier in vivo.中枢肾上腺素能系统在介导阿米替林诱导的哺乳动物血脑屏障体内改变中的作用。
J Pharmacol Exp Ther. 1982 Nov;223(2):388-95.
5
Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex.四苯嗪,一种囊泡单胺转运蛋白 2 抑制剂,通过改变大脑皮层中多巴胺和 5-羟色胺的代谢,减轻了吗啡诱导的小鼠过度活动。
Pharmacol Biochem Behav. 2018 Sep;172:9-16. doi: 10.1016/j.pbb.2018.07.002. Epub 2018 Jul 12.
6
Tetrabenazine-induced depletion of brain monoamines: mechanism by which desmethylimipramine protects cortical norepinephrine.
Eur J Pharmacol. 1984 Jul 20;102(3-4):431-6. doi: 10.1016/0014-2999(84)90563-6.
7
Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.丁苯那嗪,一种耗竭胺类的药物,也能阻断大鼠脑中的多巴胺受体。
J Pharmacol Exp Ther. 1983 Jun;225(3):515-21.
8
Amitriptyline-induced morphological alterations of the rat blood-brain barrier.阿米替林引起的大鼠血脑屏障形态学改变。
Eur J Pharmacol. 1990 Jan 25;176(1):69-74. doi: 10.1016/0014-2999(90)90133-q.
9
Antidepressants alter cerebrovascular permeability and metabolic rate in primates.抗抑郁药会改变灵长类动物的脑血管通透性和代谢率。
Science. 1982 Jul 16;217(4556):250-2. doi: 10.1126/science.7089562.
10
Association between biochemical and behavioral actions of tricyclic antidepressants.三环类抗抑郁药的生化作用与行为作用之间的关联。
Int J Neuropharmacol. 1966 Jul;5(4):299-304. doi: 10.1016/0028-3908(66)90038-4.

引用本文的文献

1
Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.咖啡因和选择性腺苷受体拮抗剂作为治疗抑郁症动机症状的新工具
Front Pharmacol. 2018 Jun 1;9:526. doi: 10.3389/fphar.2018.00526. eCollection 2018.
2
Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.动机的激活与努力相关方面:神经机制及其对精神病理学的影响。
Brain. 2016 May;139(Pt 5):1325-47. doi: 10.1093/brain/aww050.
3
The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.
VMAT-2抑制剂丁苯那嗪可改变通过T迷宫屏障选择任务所测量的与努力相关的决策:可被腺苷A2A拮抗剂MSX-3和儿茶酚胺摄取阻滞剂安非他酮逆转。
Psychopharmacology (Berl). 2015 Apr;232(7):1313-23. doi: 10.1007/s00213-014-3766-0. Epub 2014 Oct 17.
4
The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.VMAT-2抑制剂丁苯那嗪在渐进比率/随意进食选择任务中影响与努力相关的决策:与抗抑郁药物的逆转作用。
PLoS One. 2014 Jun 17;9(6):e99320. doi: 10.1371/journal.pone.0099320. eCollection 2014.
5
Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.VMAT-2 抑制剂四苯嗪的与努力相关的动机效应:对抑郁症动机症状动物模型的影响。
J Neurosci. 2013 Dec 4;33(49):19120-30. doi: 10.1523/JNEUROSCI.2730-13.2013.